Clinical trial · Observational
Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation
Study of the Role of Infection by Human Papillomavirus (HPV) in the Success Rate of Pregnancies Achieved Via Medically Assisted Procreation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective of this study is to investigate the association between the presence of HPV infection in one or both members of infertile/sub-infertile couples and the outcome of pregnancies obtained by assisted reproduction. The success of assisted medical procreation is defined as achieving a pregnancy resulting in the birth of a living, viable child.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Infertility | — | UNRESOLVED | — |
| Papillomavirus Infections | — | UNRESOLVED | — |
| Sub-fertility | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Study population
- description
- The study population consists of couples under care for infertility in the participating centers. Gamete donations are not included. Please see inclusion and exclusion criteria. Intervention: HPV screening for women Intervention: HPV screening for men
Primary outcomes (4)
- measure
- HPV test for participating women (cervicovaginal sample): positive/negative
- timeFrame
- baseline (day 0)
- measure
- HPV test for participating men (sperm sample): positive/negative
- timeFrame
- baseline (day 0)
- measure
- Birth of a living, viable child (yes/no)
- timeFrame
- end of pregnancy (expected maximum of 9 months)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Both members of each couple must have given their free and informed consent and signed the consent * Both members of each couple must be members or beneficiaries of a health insurance plan * The patient (woman) is available for follow-up after a possible pregnancy * The patient (woman) is under 43 years of age * The patient (man) is under 60 years of age * Couple consulting for infertility services in the participating reproductive medicine centers Exclusion Criteria: * One or both members of the couple are involved in another study * One or both members of the couple are in an exclusion period determined by a previous study * One or both members of the couple are under judicial protection or under any kind of guardianship * One or both members of the couple refuse to sign the consent * It is impossible to correctly inform one or both members of the couple * The patient (woman) has a contra-indication (or an incompatible combination therapy) for treatment necessary for this study * The source of sperm is a donor (i.e. it is not possible to obtain a sperm sample from the biological father for use in HPV testing).
References
Publications (0)
Data not yet available